Medi Assist Healthcare Services (MEDIASSIST) had a P/E of 19.6× on 6 Nov 2026, below the industry P/E of 34.0×, and the shares are 43% below their 52-week high. Its ROCE of 11% is the second-lowest among the 7 largest Healthcare Plans peers, and sales and net profit grew 22% and 5.9% a year over 3 years. It has almost no debt, and its dividend yield is 0.7%. It is a small-cap company with a market cap of ₹2,114 Cr, ranked 107th of 278 Healthcare Plans companies by market cap; the shares fell 49% over the past year.
- ₹282.00
- ₹285.90
- ₹281.20
- ₹285.75
- 2.8 L
Health check
- ReturnsBehind
−48.7% over a year, better than 0 of 7 peers.
- Price tagCheaper
P/E 19.6 vs industry 34.0.
- GrowthSteady
Sales +21.7%, profit +5.9% a year over 3 years.
- ProfitabilityWeak
ROCE 11.0% vs peer median 19.0%.
- Balance sheetFair
Debt 0.05× equity, interest covered 4.6×, Piotroski 4 of 9.
- Red flags1 to check
43% below its 52-week high.
Small cap
Moves with the market
Key metrics
- Market cap
- ₹2,114 Cr
- Small cap
- P/E
- 19.6
- Industry 34.0
- Price to book
- 2.39
- Peers 9.83
- Dividend yield
- 0.71%
- ROE
- 14.6%
- Peers 15.7%
- ROCE
- 11.0%
- Peers 19.0%
- Debt to equity
- 0.05
- Debt ₹46 Cr
- EPS (TTM)
- ₹14.43
- Face value ₹5
- OPM (TTM)
- 19.8%
- Net margin 11.1%
- Sales growth
- +3.9%
- Latest quarter vs a year ago
- Profit growth
- +170.8%
- Latest quarter vs a year ago
- Price to sales
- 2.20
- EV/EBITDA 12.7
Strengths and risks
Strengths
- Practically debt-free.
- Quarterly profit up 170.8% on a year ago.
- P/E of 19.6 against an industry P/E of 34.0.
- Positive operating cash flow in each of the last 4 years.
Risks to check
- 43% below its 52-week high.
About Medi Assist Healthcare Services
Medi Assist Healthcare Services Limited, together with its subsidiaries, provides third-party administration services for health insurance claims in India and internationally. The company offers MAtrix, a claims administration platform; MAven, a fraud, waste, and abuse prevention platform; MAven IDP, an intelligent document processing platform; MAven Insights, an analytics and decision intelligence platform; MAven Global, a global benefits administration…
- Headquarters
- Bengaluru
- Employees
- 6,661
- Sector
- Healthcare
- ISIN
- INE456Z01021
- Website
- mediassist.in
Price range
- Avg volume (3M)
- 2.5 L
- 1-year return
- minus 48.7%
- From 52-week high
- minus 43.5%
Peers · Healthcare Plans
| Company | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SUNPHARMASun Pharmaceutical Industries | 1,860.00 | plus 1.69% | 4,46,276 | 40.7 | 4.99 | 17.9% | 13.1% | 28.2% | 10.4% | 10.6% | 0.86% | plus 8.2% |
| DIVISLABDivi's Laboratories | 10,320.50 | plus 1.78% | 2,73,977 | 93.6 | 16.35 | 19.0% | 16.2% | 34.9% | 11.0% | 12.1% | 0.29% | plus 49.0% |
| TORNTPHARMTorrent Pharmaceuticals | 4,750.00 | plus 0.85% | 1,80,675 | 80.2 | 9.83 | 9.1% | 15.7% | 33.7% | 13.3% | 20.2% | 0.80% | plus 31.7% |
| LAURUSLABSLaurus Labs | 2,340.00 | minus 0.26% | 1,26,433 | 94.4 | 20.86 | 19.5% | 24.0% | 30.4% | 3.8% | 4.0% | 0.09% | plus 138.6% |
| APOLLOHOSPApollo Hospitals Enterprise | 8,446.00 | plus 0.90% | 1,21,441 | 54.0 | 11.45 | 19.2% | 22.5% | 15.4% | 14.8% | 33.3% | 0.24% | plus 7.2% |
| ZYDUSLIFEZydus Lifesciences | 1,197.90 | plus 0.41% | 1,19,491 | 28.6 | 4.29 | 19.0% | 14.7% | 26.2% | 16.5% | 37.0% | 0.08% | plus 22.8% |
| DRREDDYDr. Reddy's Laboratories | 1,373.00 | plus 0.51% | 1,14,462 | 40.9 | 2.96 | 14.2% | 7.3% | 15.9% | 11.0% | −1.7% | 0.58% | plus 13.8% |
| MEDIASSISTMedi Assist Healthcare Services | 282.95 | minus 0.98% | 2,114 | 19.6 | 2.39 | 11.0% | 14.6% | 19.0% | 21.7% | 5.9% | 0.71% | minus 48.7% |
| Median of 7 peers | – | 0.85% | 1,26,433 | 54.0 | 9.83 | 19.0% | 15.7% | 28.2% | 11.0% | 12.1% | 0.29% | 22.8% |
Quarterly results
| ₹ Cr | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Sep 26 |
|---|---|---|---|---|---|
| 233 | 240 | 242 | 237 | 242 | |
| 193 | 195 | 194 | 189 | 192 | |
| 39.7 | 44.6 | 48.3 | 48 | 49.2 | |
| 17.1% | 18.6% | 19.9% | 20.3% | 20.4% | |
| 2.3 | 7.6 | 1.2 | 10.5 | 3.9 | |
| 7.6 | 8.4 | 0.7 | 1.8 | 1.6 | |
| 20.9 | 21.1 | 21 | 21.8 | 21.8 | |
| – | −14.2 | – | – | – | |
| 13.5 | 8.5 | 27.9 | 34.9 | 29.7 | |
| 40.1% | 51.2% | −95.2% | 20.9% | 27.4% | |
| 7.9 | 4.2 | 53.4 | 27.7 | 21.5 | |
| 1.12 | 0.51 | 7.33 | 3.71 | 2.88 |
Profit & loss
- Sales CAGR 3Y
- +21.7%
- Profit CAGR 3Y
- +5.9%
- EPS CAGR 3Y
- +4.1%
- ROE
- 14.6%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 502 | 633 | 723 | 905 | |
| – | +26.1% | +14.2% | +25.1% | |
| 381 | 487 | 564 | 725 | |
| 121 | 146 | 160 | 180 | |
| 24.2% | 23.1% | 22.1% | 19.9% | |
| 4.2 | 11.6 | 12.2 | 10.1 | |
| 2.9 | 3.1 | 10.1 | 22.5 | |
| 26.8 | 43.1 | 55.8 | 77.1 | |
| 7.7 | −27.2 | 5.6 | −10.2 | |
| 104 | 84.4 | 112 | 80.4 | |
| 27.3% | 15.5% | 18.1% | −11.1% | |
| 74.1 | 66.9 | 90.9 | 87.9 | |
| – | minus 9.6% | +35.8% | minus 3.3% | |
| 10.76 | 9.53 | 12.85 | 12.14 |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 34.4 | 35.1 | 35.3 | 37.3 | |
| 342 | 437 | 506 | 802 | |
| 30.7 | 26.3 | 204 | 54.4 | |
| 298 | 353 | 413 | 479 | |
| 706 | 851 | 1,158 | 1,372 | |
| 56.7 | 55.1 | 84 | 93.7 | |
| 2.5 | 0.4 | – | – | |
| 5.7 | 13.2 | 16.7 | 21.4 | |
| 171 | 233 | 438 | 225 | |
| 470 | 549 | 620 | 1,033 | |
| 706 | 851 | 1,158 | 1,372 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 81.1 | 66.4 | 138 | 118 | |
| −10.5 | −54.9 | −218 | −160 | |
| −31.5 | −14.8 | 112 | 12.2 | |
| 39.1 | −3.2 | 31.9 | −29.7 | |
| −27.7 | −18.4 | −45.8 | −55.9 | |
| 53.4 | 48 | 92.3 | 61.8 | |
| −13 | −13 | −28.1 | – |
Shareholding pattern
NSE hasn’t returned a shareholding pattern for this company. Institutions hold about 63.1% (Yahoo estimate).
Major shareholders
Filings & events
News
No recent news coverage found.